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Summary While the HIV pandemic persists, and randomized clinical trials to evaluate the
effectiveness of male circumcision as an HIV prevention measure are underway with initial results
being released, there is still much debate on the implications of these studies as well as on the
feasibility of such a measure. This paper summarizes and discusses the main findings of studies of
the evidence underlying adult male circumcision to prevent HIV, explores its feasibility and the
implication for policy and future research. While the existing biological and epidemiological
evidence suggest potential reduction of the risk of HIVacquisition in circumcised men, additional
evidence from randomized trials are needed to confirm this. Even if the findings are confirmed,
the practical aspects of implementing adult circumcision would have to be carefully considered.
The feasibility of such an intervention, particularly with respect to its cost-effectiveness, safety
and acceptability, is still to be demonstrated.
# 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.Background
The control of infection with the human immunodeficiency
virus (HIV) remains a major challenge to health systems
worldwide. It is estimated that since the beginning of the
epidemic in the early 1980s, close to 20 million people have
died of HIV/AIDS.1 Meanwhile about 40 million people are
currently living with the virus and an estimated 4.8 million
new infections occurred during the year 2003 alone.1 The
continuous increase in the number of new HIV cases, despite
all the control measures being implemented so far, is an
indication of the limited effectiveness of these measures.
Efforts are being made to identify other control measures
that could cost-effectively replace or complement the cur-
rent control measures. Adult male circumcision is one such an
alternative that has been suggested to help curb HIV trans-* Tel.: +1 919 602 4268; fax: +1 919 966 4914.
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well as the feasibility, of adult male circumcision as an
intervention to prevent HIV transmission, has been a subject
of debate and disagreement within the scientific community.
This paper summarizes and discusses the main findings of
studies of the evidence underlying such an intervention, then
explores its feasibility and the implications for policy and
future research.
Biological evidence
The foreskin is thought to contain high concentrations of HIV-
target cells including Langerhan cells, CD4+ T cells and
macrophages.2 Using ex-vivo organotypic culture of foreskin
and cervical tissue biopsies, Patterson et al. showed that
these foreskin target cells express predominantly the HIV-1
chemokine co-receptor CCR5, and are more susceptible to
infection with HIV when compared to cervical tissue. Unfor-
tunately, because their study did not include a comparison toPublished by Elsevier Ltd. All rights reserved.
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the foreskin increases the risk of HIV infection compared to
skin from the penile shaft. Other HIV-specific co-receptors
such as DC-SIGN (dendritic cell-specific intercellular adhe-
sion molecule-3-grabbing nonintegrin) have been described
to be co-expressed with CD4 and CCR5 on dendritic cells in
the foreskin.3
Male circumcision could thus potentially reduce the risk of
HIVacquisition and or transmission by reducing the number of
HIV target cells in the penis. However, given that the immu-
nological function of the foreskin has not been completely
elucidated and that not all target cells are removed during
circumcision4 this biological evidence cannot be considered
conclusive. Studies correlating higher target cell expression
and higher infectivity in foreskins versus penile shaft skin are
needed for this evidence to be more compelling.
Male circumcision could also potentially indirectly reduce
the risk of HIV infection by reducing susceptibility to sexually
transmitted infections (STIs) that increase the risk of HIV
infection. The evidence that male circumcision reduces the
risk of STI acquisition is however contradictory.5 While some
studies have reported lower acquisition rates of genital ulcer
diseases,6 and lower prevalence rates of human papilloma-
virus (HPV),7 herpes simplex virus-2 (HSV-2), syphilis or
chlamydia in circumcised men,8 others found no significant
protection from STIs (including herpes and syphilis).5,9
Evidence from epidemiologic studies
Epidemiologic studies of male circumcision and HIV trans-
mission are quite numerous and diverse. This diversity is not
limited to the design used, including ecological, cross-sec-
tional and cohort studies, but also extends to the study
population, the methods of ascertaining circumcision as
well as the control for potential confounders. Thus careful
considerations have to be made when summarizing these
studies.
In the literature there are at least six systematic reviews
and one meta-analysis of these studies.10 Most of these
reviews focused only on published studies, had unclear
search strategies, or did not adequately assess for confound-
ing.10 The Cochrane review of male circumcision and HIV
transmission10 is one of the most recent reviews and appears
to be the most extensive (as it includes previous reviews) and
meticulous as it not only aimed at obtaining a summary
measure but also evaluated the quality of studies included
in the analysis. This review, carried out in 2003 and updated
in 2004,11 found no completed randomized clinical trial (RCT)
and reported three ongoing RCTs. Sixteen general population
studies were identified, of which the only cohort study
showed a protective effect of male circumcision on HIV
transmission (odds ratio OR = 0.58, 95% confidence interval
(CI): 0.36, 0.96). The 14 cross-sectional studies found het-
erogeneous crude ORs ranging from 0.28 to 1.73. However
nine of these reported adjusted ORs that ranged from 0.26 to
0.80. The only case-control study reported an OR of 1.9 (95%
CI: 0.5, 7.2). A crude analysis of these general population
studies suggests a variable effect of male circumcision,
protective in some cases and causative in others. However,
when stratified by method of ascertainment of circumcision,
in most of the studies in which the researchers directly
observed circumcision, a protective effect was shown, whilein most of the others, either a null or a causative effect were
shown. This suggests that misclassification of circumcision
may be a serious cause of bias in studies of HIV transmission
and male circumcision. It also suggests that circumcision may
need to be complete for it to be effective.
The Cochrane review further reports the effect of male
circumcision in high-risk groups. All the 18 studies (four
cohort studies, 11 cross-sectional and three case-control
studies) showed a protective effect suggesting that circum-
cision may be more effective in high-risk groups than the
general population.
One of the most interesting studies of circumcision and
HIV, because of its size and the fact that it studied both HIV
transmission and acquisition in discordant couples, was that
carried out in Rakai, Uganda.12 In this cohort study of 5507
men Gray et al. reported a crude protective effect of cir-
cumcision (risk ratio (RR) = 0.61) and a statistically non-sig-
nificant effect of post-pubertal circumcision of 0.83 (95% CI:
0.35, 2.03). However, one may argue on the validity of
clinical significance instead of statistical significance in the
interpretation of this effect (that is a close to 20% reduction
in HIV transmission which in some settings may be substan-
tial). It is also worthwhile to note that, due to the relatively
small number of people who had post-pubertal circumcision
in this study, this estimate suffers from a low precision as
evidenced by the wide confidence interval. Gray et al., in
their analysis of 187 discordant couples, found a reduction of
HIV acquisition in circumcised men (0 seroconversion/50
couples in which the male was circumcised compared with
40 seroconversions/137 couples in which the male was uncir-
cumcised). Male circumcision also seemed to reduce the
male-to-female transmission of HIV when the viral load
was low (less than 50 000 copies/ml).
Two more recent studies have addressed the topic with
specific considerations for confounding and visual ascertain-
ment of circumcision. The first was a prospective study of
2298 male patients in an STI clinic in India9 in which a
protective effect of circumcision was found only for HIV
(adjusted RR = 0.15) and not for other STIs (syphilis, gonor-
rhea, HSV). This suggests, as the authors conclude, a biolo-
gical, rather than a behavioral, explanation of the effect of
circumcision. However there is no mention of the age at
circumcision in this study. In a meticulously implemented
cross-sectional study of 845 men in Kenya, Agot et al. found
that after controlling for religion, sexual risk and age, uncir-
cumcised men where 1.5 times more likely to be HIV infected
than their circumcised counterparts.13 Age at circumcision
did not seem to make a difference.
The evidence from observational studies seems to be in
favor of circumcision having at least some effect in specific
high-risk groups. However, this evidence is not compelling as
it is based exclusively on observational studies that are very
subject to selection bias and thus limited in their general-
izability. Furthermore, few of these studies address the issue
of when to circumcise (at birth, puberty, or adulthood).
Some authors caution that the observed effect of circum-
cision may be due to confounding from religious and cultural
differences, sexual behaviors and hygiene practices, arguing
that circumcised men tend to be from religions that lead
them to have behaviors that reduce their risk.9 Though there
is this possibility for residual confounding, it is worth noting
that because circumcision is protective, confounding caused
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increase in the risk or odds ratio), towards the null and
adjusting for them will actually (as seen in most of the
studies) result in estimates that are more protective. Thus
skepticism based on confounding will be valid only for non-
protective risk factors like age.
Three randomized clinical trials are being conducted in
sub-Saharan Africa to better understand the evidence from
observational studies. The results of the RCT conducted in
South Africa were recently made available.14 These show a
63% reduction in the risk of acquiring HIV infection over 21
weeks of follow-up in circumcised, 18—24 year-old males.
The incidence rate in the intervention group was 0.7 per 100
person years while in the control group it was 2.2 per 100
person years — a crude incidence rate ratio of 0.35 (95% CI:
0.20, 0.60). The other two RCTs (in Uganda and Kenya) are
still to be completed.
In the light of these findings from epidemiological studies
and considering that close to 5 million new cases of HIV were
estimated for the year 20031 and that some other measures
(like condoms) being used to curb HIV never needed proof
from an RCT, one wonders if it would not be right to start
implementing adult male circumcision as a public health
intervention. The decision would have been easier to make
if the evidence from epidemiological studies was unequi-
vocal and if the intervention was going to be easy and
feasible. As discussed above the evidence from observa-
tional studies is not so compelling and the only RCT result
available is yet to be replicated.
The feasibility of male circumcision as a
public health intervention to prevent HIV
For male circumcision to be implemented as a public health
intervention it will have to be acceptable to the community
in which it is being implemented, be easily implemented and
cost-effective.
Acceptability
Circumcision is traditionally done for religious, ethnic, or
medical reasons.15 The greatest challenge facing this inter-
vention is the paradoxical situation by which it will be least
acceptable in communities that need it the most (tradition-
ally non-circumcising communities) and it will bemost accep-
table in communities in which it is likely to be least effective
because people already practice it. Studies of the community
acceptance in Kenya,16,17 South Africa18,19 and Botswana20
have reported acceptability rates of 51—61% in uncircum-
cised men. These rates may seem acceptable if the method
was really effective and not costly. The stigma associated
with circumcision in some communities, the fear of pain and
bleeding, reduced sexual pleasure and limited access to
health facilities may, however, hamper the effective number
of people who may accept the procedure once it is proposed.
Correlated with acceptability, is the risk of a false percep-
tion of security from circumcision that may arise if it is
offered to people. In one study in South Africa, 30% of
circumcised men believed that circumcised men could safely
have sex with multiple partners.21 This risk is in fact also
existent for other measures like vaccines, or drugs and couldbe lessened by an effective information and education sys-
tem as an adjunct to these measures. Caution has to be taken
to make sure that communities do not perceive circumcision
as ‘The’ way to prevent HIV.
Simplicity and safety
Circumcision has generally been regarded as a surgical pro-
cedure, needing trained personnel and facilities, and at risk
of complications such as bleeding and infection. There is a
scarcity of data on the frequency of complications following
adult circumcision, particularly for developing countries. A
study in Turkey reported close to 85% of men having compli-
cations when circumcised in non-medical settings; this com-
pared to 2% when circumcision was conducted by licensed
surgeons.22 Eleven percent of 249 consecutive men of all ages
having circumcisions in sterile conditions in hospitals in
Nigeria and Kenya developed complications.23
It is worth noting that technologies have recently been
developed that allow for the use of a single-use disposable
device, requiring little training and practically no surgical
instruments. If confirmed to be effective and safe these could
potentially cut down both the risk of adverse outcomes and
the cost, while improving acceptability. Also, providing cir-
cumcision in medical settings as opposed to traditional set-
tings will probably reduce the risk of potential adverse
outcomes.
Cost—benefit
To the author’s knowledge, there has been no published study
of the cost-effectiveness of adult male circumcision to pre-
vent HIV. Potentially, the cost of the procedure itself as well
as the cost of training health personnel, information, educa-
tion and communication as well as for maintaining the health
facilities will need to be considered. The use of modern
techniques as opposed to traditional surgery may however
reduce cost. In high HIV-prevalence settings the relative cost
of averting a case of HIV infection as opposed to having to
manage that case will probably be in favor of the interven-
tion. Other benefits that may result from a public health
intervention that includes adult male circumcision, include
the opportunity to bring men in contact with the healthcare
system and increase awareness of the HIV pandemic, to
increase voluntary counseling and testing, to increase the
acceptability of neonatal circumcision and also the benefit of
reducing other penile infections such as HPV (which could be
transmitted to their female partners and cause cervical
cancer) or penile cancer. Data on the cost—benefit of adult
male circumcision are needed to guide policy.
Other considerations
In addition to the considerations above, the implementation
of such an intervention will have to carefully consider legal,
ethical, and human rights issues.24 The opportunity cost from
reducing resources to other programs, age at circumcision,
circumcision in hospitals versus traditional settings, manage-
ment of complications and how to deal with concurrent
female genital mutilation that is being prohibited, are exam-
ples of issues that need to be tackled.
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Adult male circumcision could potentially reduce the trans-
mission efficiency of HIV and thus reduce the reproductive
rate of HIV in a population. Therefore, it could eventually be
one of the tools used in preventing HIV within a comprehen-
sive HIV control program. However, because of its limited
feasibility, more evidence on its effectiveness is needed so as
to increase its acceptability (both in the population and the
scientific community) as well as to justify the addition, and/
or displacement of meager resources from other strategies,
towards its implementation.
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